The biologics market is expected to grow to nearly €25 billion by 2028
Bayer and Kimitec have entered into a global strategic partnership by which they will combine biologics discovery capabilities and comprehensive crop protection portfolios.
Kimitec, based in Almería, Spain, has 15 years of experience in the research and discovery of natural molecules and compounds for agricultural and food sectors. The biotechnology company focuses on delivering solutions for agriculture and livestock. The company’s MAAVi Innovation Centre is said to be Europe’s largest for research into biopesticides, probiotics and prebiotics.
The new partnership will focus on accelerating the development and commercialisation of biological crop protection solutions and biostimulants. Kimitec’s MAAVi Innovation Centre will provide its LINNA AI platform, which will mean quicker time-to-results and discovery of natural molecules. Bayer says that this will ‘fuel its ability to market the next generation of biological solutions’. The partners will also benefit from Bayer’s global infrastructure which includes field testing, and product support.
‘Our work with Kimitec offers a unique accelerated path to innovative biological solutions that will help us deliver on our shared vision for a new generation of effective, safe and sustainable solutions derived from nature,’ said Benoit Hartmann, Head of Biologics for Bayer’s Crop Science Division.
Bayer says that the biologics market is expected to grow to nearly €25 billion by 2028, as consumer demand for low-and no-residue food products grows, and retailers’ food sourcing standards drive growers to look to new innovations in crop protection.
Felix Garcia, CEO for Kimitec said; ‘This agreement with Bayer is closely aligned with our 360 Open Innovation strategy, to partner with world leading innovation companies to bring meaningful and sustainable solutions for the farmer, the consumer, and the planet.’